$73.26 2.9%
Price vs. AI Score (Last 150 days)
Data gathered: December 6

Data Bits

Data Bits Value / Change Benchmark
Job Posts 37,000 -3.9%
App downloads 9,772 -0.3%
Sentiment 91 -6.2%
Webpage traffic 3,313,000 1.7%
Employee Rating 63 0%
Google Adspend $1,740 -82.7% N/A
Google Trends 33 -55.4%
Linkedin Employees 119,368 N/A
Lobbying Cost $513,000 0%
Patents 143 0.7%
4chan Mentions 0%
Facebook Engagement 1,115 -2%
Facebook followers 41,751 0%
Stocktwits Mentions 58 625%
Stocktwits Subscribers 26,421 0.1%
Twitter Followers 67,616 -0%
Youtube Subscribers 41,100 0%
Instagram Followers 17,303 0.1%
News Mentions 4 300%
Reddit Mentions 13 1200%
ESG 92 0%
Business outlook 43 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About CVS Health

CVS Health Corporation provides health services in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services.

CVS Health
Price $73.26
Target Price Sign up
Market Cap $88.1B
Dividend Yield 0.0353
Industry Retail

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '2389.8B55.3B34.5B2.26B4.22B
Q2 '2388.9B54.7B34.2B1.9B3.73B
Q1 '2385.3B52.3B33B2.14B3.86B
Q4 '2283.8B196B-112B2.3B4.15B
Q3 '2281.2B53.3B27.9B-3.41B-3.43B

Insider Transactions

LUDWIG EDWARD J filed to buy 20,630 shares at $70.5.
November 6 '23
Clark James David filed to sell 4,698 shares at $74.9.
August 4 '23
Lynch Karen S filed to buy 431,392 shares at $69.8.
May 5 '23
Moriarty Thomas M filed to sell 608,129 shares at $98.2.
December 16 '22
Lotvin Alan filed to sell 109,183 shares at $104.
August 5 '22
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.